WST 📈 West Pharmaceutical Services - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US9553061055
WST: Stoppers, Seals, Syringe Components, Films, Coatings, Containers, Injectors
West Pharmaceutical Services Inc is a leading global provider of containment and delivery systems for injectable drugs and healthcare products, with operations spanning the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company's business is divided into two main segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment focuses on developing and manufacturing a range of innovative products, including stoppers and seals for injectable packaging systems, syringe and cartridge components, and administration systems that utilize advanced technologies to enhance the safe delivery of drugs. Additionally, this segment offers a variety of services, such as films, coatings, washing, vision inspection, and sterilization processes, to improve the quality of packaging components.
The Proprietary Products segment also provides a range of specialized solutions, including Crystal Zenith, a cyclic olefin polymer used in the production of vials, syringes, and cartridges, as well as self-injection devices. Furthermore, the company offers integrated solutions, including analytical lab services, pre-approval primary packaging support, engineering development, regulatory expertise, and after-sales technical support, to cater to the needs of biologic, generic, and pharmaceutical drug companies. This comprehensive suite of products and services enables West Pharmaceutical Services Inc to support its customers throughout the entire product development and commercialization process.
The Contract-Manufactured Products segment, on the other hand, is involved in the design, manufacture, and automated assembly of devices used in various applications, including surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment serves a diverse range of customers, including pharmaceutical, diagnostic, and medical device companies. West Pharmaceutical Services Inc utilizes a combination of its sales force, distribution network, contract sales agents, and regional distributors to sell and distribute its products globally. With a rich history dating back to 1923, the company is headquartered in Exton, Pennsylvania, and has established itself as a trusted partner to the healthcare industry.
As a publicly traded company listed on the New York Stock Exchange (NYSE) under the ticker symbol WST, West Pharmaceutical Services Inc is committed to delivering high-quality products and services that meet the evolving needs of the healthcare industry. With a strong focus on innovation, customer satisfaction, and regulatory compliance, the company continues to expand its product offerings and global reach, solidifying its position as a leading provider of containment and delivery systems for injectable drugs and healthcare products. The company's web presence can be found at https://www.westpharma.com, and its common stock is classified under the GICS Sub Industry: Health Care Supplies, with the ISIN code US9553061055.
Additional Sources for WST Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
WST Stock Overview
Market Cap in USD | 23,587m |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
GiC Sub-Industry | Health Care Supplies |
IPO / Inception | 1978-01-13 |
WST Stock Ratings
Growth 5y | 36.4% |
Fundamental | 61.0% |
Dividend | 52.4% |
Rel. Strength Industry | -465 |
Analysts | 4.2/5 |
Fair Price Momentum | 313.39 USD |
Fair Price DCF | 114.89 USD |
WST Dividends
Dividend Yield 12m | 0.24% |
Yield on Cost 5y | 0.54% |
Annual Growth 5y | 4.77% |
Payout Consistency | 96.4% |
WST Growth Ratios
Growth Correlation 3m | 73.6% |
Growth Correlation 12m | -72.7% |
Growth Correlation 5y | 41.8% |
CAGR 5y | 17.23% |
CAGR/Mean DD 5y | 0.90 |
Sharpe Ratio 12m | -0.09 |
Alpha | -30.19 |
Beta | 0.90 |
Volatility | 34.40% |
Current Volume | 2444.4k |
Average Volume 20d | 530k |
As of December 22, 2024, the stock is trading at USD 331.40 with a total of 2,444,400 shares traded.
Over the past week, the price has changed by -1.39%, over one month by +7.53%, over three months by +5.15% and over the past year by -8.52%.
Yes, based on ValueRay Fundamental Analyses, West Pharmaceutical Services (NYSE:WST) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 61.00 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of WST as of December 2024 is 313.39. This means that WST is currently overvalued and has a potential downside of -5.43%.
West Pharmaceutical Services has received a consensus analysts rating of 4.20. Therefor, it is recommend to buy WST.
- Strong Buy: 5
- Buy: 2
- Hold: 3
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, WST West Pharmaceutical Services will be worth about 347.2 in December 2025. The stock is currently trading at 331.40. This means that the stock has a potential upside of +4.76%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 361.6 | 9.1% |
Analysts Target Price | 400.7 | 20.9% |
ValueRay Target Price | 347.2 | 4.8% |